• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,502.12 579.48
( 0.75%)
Global Indices
Nasdaq
52,333.78 -6.42
(-0.01%)
Dow Jones
7,505.37 -14.99
(-0.20%)
Hang Seng
68,854.54 -1,620.42
(-2.30%)
Nikkei 225
10,664.80 186.46
(1.78%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
18.92
127.73
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.5
 

mercantile ventures ltd
Visaka Industries consolidated net profit rises 174.67% in the March 2026 quarter
May 18,2026
Net profit of Visaka Industries rose 174.67% to Rs 40.02 crore in the quarter ended March 2026 as against Rs 14.57 crore during the previous quarter ended March 2025. Sales rose 12.66% to Rs 479.75 crore in the quarter ended March 2026 as against Rs 425.85 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 85.36 crore in the year ended March 2026 as against net loss of Rs 3.01 crore during the previous year ended March 2025. Sales rose 8.72% to Rs 1677.86 crore in the year ended March 2026 as against Rs 1543.28 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales479.75425.85 13 1677.861543.28 9
OPM %10.6010.45 -8.316.41 -
PBDT44.8436.44 23 112.7462.62 80
PBT28.1420.33 38 47.45-2.00 LP
NP40.0214.57 175 85.36-3.01 LP